The Lancet Haematology
Journal Title
- The Lancet Haematology
ISSN
- P 2352-3026 | 2352-3026
Publisher
- Elsevier Limited
- Elsevier
Listed on(Coverage)
| JCR | 2015-2019 |
|---|---|
| SJR | 2015-2019 |
| CiteScore | 2015-2019 |
| SCIE | 2015-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- The Lancet Haematology launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence that advocate a change in, or illuminate, haematological clinical practice. The Lancet Haematology builds on The Lancet journals' reputation for publishing high-impact research and covers the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. Following in The Lancet tradition, the journal is stringently edited and peer-reviewed to ensure scientific merit and clinical relevance. All original research is Fast Track peer reviewed for online publication within 8 weeks of submission and receives global exposure to the medical community via our online platforms thelancet.com and ScienceDirect. For selected high-impact research, the journal has a dedicated press office to facilitate worldwide media coverage, ensuring extensive global exposure of your research. Visit www.thelancet.com/haematology for more information.